141 related articles for article (PubMed ID: 16624572)
1. Partial purification of human parathyroid hormone 1-84 as a thioredoxin fusion form in recombinant Escherichia coli by thermoosmotic shock.
Guo QR; Wei DZ; Tong WY
Protein Expr Purif; 2006 Sep; 49(1):32-8. PubMed ID: 16624572
[TBL] [Abstract][Full Text] [Related]
2. Extracellular production of human parathyroid hormone as a thioredoxin fusion form in Escherichia coli by chemical permeabilization combined with heat treatment.
Fu XY; Tong WY; Wei DZ
Biotechnol Prog; 2005; 21(5):1429-35. PubMed ID: 16209546
[TBL] [Abstract][Full Text] [Related]
3. Large scale preparation of recombinant human parathyroid hormone 1-84 from Escherichia coli.
Liu Q; Lin J; Liu M; Tao X; Wei D; Ma X; Yang S
Protein Expr Purif; 2007 Aug; 54(2):212-9. PubMed ID: 17449274
[TBL] [Abstract][Full Text] [Related]
4. Protein purification by fusion with an environmentally responsive elastin-like polypeptide: effect of polypeptide length on the purification of thioredoxin.
Meyer DE; Trabbic-Carlson K; Chilkoti A
Biotechnol Prog; 2001; 17(4):720-8. PubMed ID: 11485434
[TBL] [Abstract][Full Text] [Related]
5. Enterokinase cleavage of fusion proteins for preparation of recombinant human parathyroid hormone 1-34.
Xiu ZY; Zhou HY; Yu Y; Dai JF; Chen CQ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):469-74. PubMed ID: 12098770
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of soluble B lymphocyte stimulator from recombinant Escherichia coli.
Guo QR; Tong WY; Wei DZ; Tao XY
Prikl Biokhim Mikrobiol; 2008; 44(2):187-92. PubMed ID: 18669261
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of thioredoxin fusion proteins.
McCoy J; La Ville E
Curr Protoc Protein Sci; 2001 May; Chapter 6():Unit 6.7. PubMed ID: 18429194
[TBL] [Abstract][Full Text] [Related]
8. The chromatography-free release, isolation and purification of recombinant peptide for fibril self-assembly.
Hartmann BM; Kaar W; Yoo IK; Lua LH; Falconer RJ; Middelberg AP
Biotechnol Bioeng; 2009 Dec; 104(5):973-85. PubMed ID: 19530081
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of thioredoxin fusion proteins.
McCoy J; Lavallie E
Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.8. PubMed ID: 18265135
[TBL] [Abstract][Full Text] [Related]
10. Optimization of an osmotic shock procedure for isolation of a protein product expressed in E. coli.
Rathore AS; Bilbrey RE; Steinmeyer DE
Biotechnol Prog; 2003; 19(5):1541-6. PubMed ID: 14524717
[TBL] [Abstract][Full Text] [Related]
11. New fusion protein systems designed to give soluble expression in Escherichia coli.
Davis GD; Elisee C; Newham DM; Harrison RG
Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
[TBL] [Abstract][Full Text] [Related]
12. Expression of bioactive soluble human stem cell factor (SCF) from recombinant Escherichia coli by coproduction of thioredoxin and efficient purification using arginine in affinity chromatography.
Akuta T; Kikuchi-Ueda T; Imaizumi K; Oshikane H; Nakaki T; Okada Y; Sultana S; Kobayashi K; Kiyokawa N; Ono Y
Protein Expr Purif; 2015 Jan; 105():1-7. PubMed ID: 25286400
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the production and purification processes of carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 by heterologous expression in Escherichia coli.
Jasniewski J; Cailliez-Grimal C; Gelhaye E; Revol-Junelles AM
J Microbiol Methods; 2008 Apr; 73(1):41-8. PubMed ID: 18316133
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli.
Xu X; Jin F; Yu X; Ji S; Wang J; Cheng H; Wang C; Zhang W
Protein Expr Purif; 2007 Jun; 53(2):293-301. PubMed ID: 17300953
[TBL] [Abstract][Full Text] [Related]
15. Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner.
Tomala M; Lavrentieva A; Moretti P; Rinas U; Kasper C; Stahl F; Schambach A; Warlich E; Martin U; Cantz T; Scheper T
Protein Expr Purif; 2010 Sep; 73(1):51-7. PubMed ID: 20381622
[TBL] [Abstract][Full Text] [Related]
16. A simple method for production and purification of soluble and biologically active recombinant human leukemia inhibitory factor (hLIF) fusion protein in Escherichia coli.
Imsoonthornruksa S; Noisa P; Parnpai R; Ketudat-Cairns M
J Biotechnol; 2011 Feb; 151(4):295-302. PubMed ID: 21219946
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
[TBL] [Abstract][Full Text] [Related]
18. Efficient preparation of an acyclic permutant of kalata B1 from a recombinant fusion protein with thioredoxin.
Cui T; Gao Y; Liew OW; Puah CM; Gutte B
J Biotechnol; 2007 Jul; 130(4):378-84. PubMed ID: 17610979
[TBL] [Abstract][Full Text] [Related]
19. Purification of streptomycin adenylyltransferase from a recombinant Escherichia coli.
Jana S; Karan G; Deb JK
Protein Expr Purif; 2005 Mar; 40(1):86-90. PubMed ID: 15721775
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of a novel recombinant peptide derived from hPTH(1-34).
Chunxiao W; Jingjing L; Yire X; Jingning L; Kai K; Liang S; Yi L; Rasco B
Protein Expr Purif; 2011 Sep; 79(1):156-63. PubMed ID: 21569852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
